The Potential of NAMs: Fulfilling Critical Unmet Drug Discovery Needs

DATE

October 22, 2025

TIME

8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST - Duration: 60 Minutes

Overview

Novel Alternative Methods (NAMs) are emerging as an important strategy for improving the success rate in drug discovery. This requires that in vitro models much more accurately and reliably predict the effect of drugs when administered to a human.

We will review approaches that are being taken to achieve these goals, including the development of more physiologically relevant and translational cellular models, improvement of existing “gold standard” technologies, and future strategies that have the potential to incorporate much larger data sets than any animal model ever could.

Key Learning Objectives:

What NAMs are and why they are needed
Where biological models are expanding to meet this need
How existing platforms can be optimized for use as NAMs
How artificial intelligence (AI) has the potential to impact NAMs
Where we can look to further expand NAM predictability

Speakers

Alastair J. King, Ph.D.
Head of Biology,
Eurofins Discovery

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

Address 1*

City*

State*

Zip / Post Code*

Country/Territory/Area*

Business Phone*

Where are you at in the drug discovery process?*

Are you using or do you plan to use NAMs in your next drug discovery program?*

What knowledge are you hoping to obtain from this webinar?*

I would like to receive C&EN’s weekly newsletter with the latest in chemistry news

I would like to receive more information on products and services from the American Chemical Society

address2

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

Brought to you by:

View On Demand Webinars